Also seen on reports as: Hcy, tHcy (total homocysteine), Plasma Homocysteine
What is Homocysteine?
Homocysteine is an amino acid the body makes as a normal step in protein metabolism. Under healthy conditions, it is quickly converted into other useful molecules — but this conversion needs specific B vitamins (vitamin B12, folate, and vitamin B6) to work properly. When any of these is deficient, homocysteine builds up in the blood.
Persistently raised homocysteine has been studied as a possible cardiovascular risk marker — high levels are associated with greater risk of heart attack, stroke, and clots in some populations. However, large clinical trials of lowering homocysteine with B-vitamin supplements have generally not reduced cardiovascular events, so its role as an actionable risk marker is debated.
The test is run on a small blood sample drawn from a vein. NABL-accredited Indian labs report homocysteine in micromoles per litre (µmol/L). Sample handling matters — the blood must be processed promptly, because homocysteine continues to rise in unspun blood at room temperature.
Why doctors order it
Homocysteine is most commonly ordered to evaluate suspected vitamin B12 or folate deficiency, particularly when serum B12 is borderline and the picture is unclear. Methylmalonic acid (MMA) is another similar marker — together, MMA and homocysteine help confirm functional B12 deficiency when serum B12 alone is ambiguous.
It is also ordered in the work-up of unexplained venous thrombosis (deep vein thrombosis, pulmonary embolism), recurrent miscarriage, and unexplained premature cardiovascular disease — particularly when standard risk factors do not explain the picture. It is sometimes part of an extended cardiovascular-risk panel in younger Indian adults with strong family history.
In Indian practice, homocysteine has particular relevance because vegetarianism is widespread and B12 deficiency is common — many Indian vegetarians have mildly raised homocysteine simply because of low B12 intake. Correcting the deficiency usually lowers homocysteine.
What the result means
Mildly raised homocysteine in the 15–30 µmol/L range is common and is most often related to low B12, low folate, or both — rather than to a primary cardiovascular problem. Treating the underlying vitamin deficiency typically lowers homocysteine over weeks to months.
Moderately raised homocysteine (30–100 µmol/L) is less common and usually points to more substantial B-vitamin deficiency, certain kidney conditions, hypothyroidism, or specific medications. Severely raised levels (>100 µmol/L) are rare and usually indicate an inherited enzyme defect (homocystinuria) or a major underlying medical condition needing specialist input.
Whether to actively lower raised homocysteine with supplements is a clinical judgement. The evidence for cardiovascular benefit from supplementation is weak in large trials, but treating an underlying B12 or folate deficiency is important regardless of the cardiovascular question — these deficiencies cause anaemia, neurological problems, and pregnancy issues independent of homocysteine.
Reference range
Values in µmol/L (micromoles per litre)
- Typical adult range
- Roughly 5 – 15 µmol/L (lab-dependent)
- Mildly raised
- 15 – 30 µmol/L — most often B12 / folate deficiency, kidney, or thyroid
- Moderately raised
- 30 – 100 µmol/L — significant deficiency, certain medications, or other underlying causes
- Severely raised
- Above 100 µmol/L — uncommon; usually inherited or major underlying condition
- Pregnancy
- Naturally lower than non-pregnant adult range
Sample handling affects results — homocysteine rises in unspun blood at room temperature, so prompt processing matters. Reference ranges differ slightly between Indian labs. The test is interpreted alongside vitamin B12, folate, kidney function, and (in pregnancy or family history of clots) sometimes additional markers.
Common factors that affect the result
B-vitamin status is the most common modifiable driver. Low vitamin B12 — widespread in Indian vegetarians, the elderly, and people on long-term acid-suppressing medications (PPIs) — and low folate both raise homocysteine. Vitamin B6 deficiency is a less common contributor. Replacing the deficient vitamin usually lowers homocysteine over weeks.
Several medications affect homocysteine. Methotrexate (used for autoimmune disease and some cancers), some anti-seizure medications (phenytoin, carbamazepine), metformin (slightly, through B12 effects over long-term use), and nitrous oxide can raise it. Estrogen-containing oral contraceptives and hormone therapy can lower it modestly.
Kidney function affects homocysteine — chronic kidney disease raises homocysteine because the kidneys help clear it. Hypothyroidism, certain genetic enzyme variants (MTHFR polymorphisms, common in some populations), heavy coffee intake, smoking, and high alcohol intake also tend to raise it. Pregnancy lowers homocysteine; intense exercise can transiently shift it.
When to talk to your doctor
- Your homocysteine is raised and your vitamin B12 or folate is also low — this is the most common pattern and usually responds to correcting the underlying deficiency.
- Your homocysteine is raised and you are vegetarian, particularly long-term vegan — B12 supplementation is often the first step.
- You have had an unexplained venous clot (DVT or pulmonary embolism), recurrent miscarriage, or unexplained early cardiovascular event — homocysteine may be one of several tests in the work-up.
- Your homocysteine is significantly raised (above 30 µmol/L) — further evaluation of kidney function, thyroid, medications, and (in selected cases) genetic causes is usually arranged.
- You are on long-term methotrexate, anti-seizure medication, or PPI therapy — homocysteine monitoring may be part of safe long-term use.
Related tests
Sources
- Lipid Association of India (LAI) Cardiovascular Risk Position Papers — Lipid Association of India
- Cardiological Society of India (CSI) Position Papers — Cardiological Society of India
- ICMR-NIN Dietary Guidelines on B-vitamins and Folate — Indian Council of Medical Research — National Institute of Nutrition
- FOGSI Guidelines on Recurrent Pregnancy Loss — Federation of Obstetric and Gynaecological Societies of India
- AHA Scientific Statement on Homocysteine and Cardiovascular Disease — American Heart Association
See our medical disclaimer for what this content is and is not.